Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancer

被引：0
|
作者：
Paul Workman
Marissa V Powers
机构：
[1] Paul Workman and Marissa V. Powers are in the Cancer Research UK Centre for Cancer Therapeutics,
[2] The Institute of Cancer Research,undefined
[3] Haddow Laboratories,undefined
[4] 15 Cotswold Road,undefined
[5] Sutton,undefined
[6] Surrey SM2 5NG,undefined
[7] UK. paul.workman@icr.ac.uk,undefined
来源：
Nature Chemical Biology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chemical probes reveal Hsp90 to be a key molecule for the control of apoptosis in small-cell lung cancer—with important implications for Hsp90 biology and cancer treatment.
引用
收藏
页码：455 / 457
页数：2
相关论文
共 50 条
  • [41] A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2
    Sidera, Katerina
    Gaitanou, Maria
    Stellas, Dimitris
    Matsas, Rebecca
    Patsavoudi, Evangelia
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (04) : 2031 - 2041
  • [42] Hsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small cell cell lung cancer cell models
    Codony-Servat, J.
    Codony-Servat, C.
    Viteri, S.
    Ito, M.
    Chaib, I.
    Bracht, J.
    Molina-Vila, M. A.
    Karachaliou, N.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90
    Matokanovic, Mirela
    Barisic, Karmela
    Filipovic-Grcic, Jelena
    Maysinger, Dusica
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (01) : 149 - 158
  • [44] Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC)
    Akram, Anam
    Khalil, Sara
    Halim, Sobia Ahsan
    Younas, Hooria
    Iqbal, Sadaf
    Mehar, Saima
    CURRENT DRUG METABOLISM, 2018, 19 (04) : 335 - 341
  • [45] Expression and role of HSP90α in esophageal squamous cell carcinoma
    Li, Xiu-Juan
    Liu, Gui-Tao
    Guo, Yu
    Su, Li-Ping
    Zhang, Zhi-Qiang
    Zhang, Xiang-Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (12): : 23092 - 23101
  • [46] HSP90 mediates the connection of multiple programmed cell death in diseases
    Peng, Caiwang
    Zhao, Fengyan
    Li, Hengli
    Li, Ling
    Yang, Yantao
    Liu, Fang
    CELL DEATH & DISEASE, 2022, 13 (11)
  • [47] HSP90 mediates the connection of multiple programmed cell death in diseases
    Caiwang Peng
    Fengyan Zhao
    Hengli Li
    Ling Li
    Yantao Yang
    Fang Liu
    Cell Death & Disease, 13
  • [48] Identification of synergistic drug combinations with the oral HSP90 inhibitor Debio 0932 in non-small cell lung cancer and renal cell cancer
    Langdon, Casey G.
    Wiedemann, Norbert
    Hajjami, Helene Maby-El
    Held, Mathew A.
    Platt, James T.
    Vuagniaux, Gregoire
    Bosenberg, Marcus W.
    Stern, David F.
    Levy, Frederic
    CANCER RESEARCH, 2014, 74 (19)
  • [49] Role of stereotactic radiotherapy in the management of small-cell lung cancer
    Lucia, Francois
    Antoni, Delphine
    Vaugier, Loig
    Duverge, Loig
    Thureau, Sebastien
    Bourbonne, Vincent
    CANCER RADIOTHERAPIE, 2024, 28 (6-7): : 628 - 632
  • [50] The role of surgery in small-cell lung cancer: A case history
    Colder, CD
    Postmus, PE
    ANNALS OF ONCOLOGY, 1996, 7 (03) : 303 - 309
12345